Effect of ticlopidine on platelet-derived microparticles in patients with connective tissue diseases

Haemostasis

Volumn 29, Issue 5, 1999, Pages 255-261

  Kagawa, Hideo ^a   Nomura, Shosaku ^a   Nagahama, Minori ^a   Ozaki, Yoshio ^a   Fukuhara, Shirou ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Collagen diseases; Peripheral circulation disorders; Platelet derived microparticles; Ticlopidine; Vascular damage

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; TICLOPIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLLAGEN DISEASE; CONNECTIVE TISSUE DISEASE; DRUG EFFECT; FEMALE; HUMAN; MALE; PARTICLE SIZE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0342369575     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022510     Document Type: Article

References (25)

1. Kagawa H, Okubo S, Yasunaga K: Plasma coagulation and fibrinolysis parameters in patients with collagen diseases, and analysis of the multi-meric structure of von Willebrand factor (vWF). Int J Hematol 1991; 54:429-439.
2. Angles-Cano E, Sultan Y, Cluvel J-P: Predisposing factors to thrombosis in systemic lupus crythematosus. Arthritis Rheum 1982;25:1271-1277.
3. Rick ME, Hover LW: Haemostatic disorders in systemic lupus erythematosus. Clin Rheum Dis 1982;1: 583-596.
4. Kahaleh MB, Osborn I, Leroy EC: Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. Ann Intern Med 1981;94:482-484.
5. Murakami T, Komiyama Y, Masuda M, Kido H, Nomura S, Fukuhara S, Karakawa, M, Iwasaka T, Takahashi H: Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease. Eur J Clin Invest 1996;26:996-1003.
6. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ: Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. J Biol Chem 1989;264:17049-17057.
7. 3 in platelet microparticle generation by collagen plus thrombin. Haemostasis 1996;26:31-37.
8. Hamilton KK, Hattori R, Esmon CT, Sims PJ: Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose a catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 1990;265:3809-3814.
9. Kagawa H, Komiyama Y, Nakamura S, Miyake T, Miyazaki Y, Hamamoto K, Msuda M, Takahashi H, Nomura S, Fukuhara S: Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells. Thromb Res 1998;6:297-304.
10. Cachet C, Hechler B, Leon C, Vial C, Leray C, Ohlmann P, Cazenave JP: Activation of ADP receptors and platelet function. Thromb Haemost 1997;78:271-275.
11. Jantzen HM, Gousset L, Bhaskar V, Vincent D, Tai A, Reynolds EE, Conley PB: Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. Thromb Haemost 1999;81:111-117.
12. Savi P, Nurden P, Nurden AT, Levy-Toledano S, Herbert JM : Clopidogrel: A review of its mechanism of action. Platelet 1998;9:251-255.
13. Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H, Komiyama Y, Fujimura Y, Ikeda Y, Fukuhara S: High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996; 88:3456-3464.
14. Nomura S, Suzuki M, Katsura K, Xie GL, Miyazaki Y, Miyake T, Kido H, Kagawa H, Fukuhara S: Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995;116:235-240.
15. Miyake T, Nomura S, Komiyama Y, Miyazaki Y, Kagawa H, Masuda M, Takahashi H, Fujimura Y, Ikeda Y, Fukuhara S: Effect of a new monoclonal anti-glycoprotein IX antibody. KMP-9, on high shear-induced platelet aggregation. Thromb Haemost 1997;78:902-909.
16. Nomura S, Nagata H, Oda K, Kokawa T, Yasunaga K: Effects of EDTA on membrane glycoprotein IIb-IIIa complex: Analysis using flow cytometry. Thromb Res 1987;47:47-58.
17. srk activation by an anti-glycoprotein Ib monoclonal antibody. Blood 1997;89:1590-1598.
18. Biondi ML, Marasini B, Bianchi E, Agostoni A: Plasma free and intra-platelet serotonin in patients with Raynaud's phenomenon. Int J Cardiol 1988;19:335-339.
19. Farconi S, Guerrini M, Rossi C, Pecchi S: Local increase of blood viscosity during cold induced Raynaud's phenomenon. Vasa 1979;8: 116-120.
20. Hagiwara E, Gourley MF, Lee S, Klinman DM: Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum 1996;39:379-385.
21. 2 antagonist on the coagulation activity in patients of collagen diseases with Raynaud's phenomenon. Ther Res 1998;19:263-269.
22. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RFA. Griffin JH: Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991;77:2641-2648.
23. Dahlback B, Wiedmer T, Sims PJ: Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles. Biochemistry 1992;31:12769-12777.
24. Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ: Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991;266:17261-17268.
25. Barry OP, Pratico D, Lawson JA, FitzGerald GA: Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997; 99:2118-2127.